Ospedale Misericordia e Dolce
12
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
58%
7 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Immunisation Status and Safety of Vaccines in Italian MS Patients
Role: collaborator
Tailored Hydration Based on Bioimpedance Analysis for Prevention of Contrast Induced Acute Kidney Injury
Role: lead
Prevena™ Incision Management System vs Conventional Management for Wound Healing
Role: lead
Personalized Versus Standard Hydration for Prevention of CI-AKI: a Randomized Trial With Bioimpedance Analysis
Role: lead
Statins for Prevention of Contrast Induced Nephropathy
Role: lead
Early Hydration in Acute Myocardial Infarction
Role: lead
Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction
Role: lead
INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer
Role: lead
Single Dose Steroid Before Thyroidectomy for Benign Disease to Improve Postoperative Nausea, Pain, and Vocal Function
Role: lead
Hydration and Contrast-Induced Nephropathy in Primary Angioplasty
Role: lead
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
Role: lead
Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity
Role: lead
All 12 trials loaded